“Why Aging is a Disease With David Sinclair” — Moonshots EP #18

Episode summary

Diamandis and Harvard geneticist David Sinclair make the core case that aging is a disease — a software problem, not a hardware limit. Sinclair frames it around his lab’s discovery that a “backup copy” of youthful epigenetic software exists in the body and can be reset (published December 2020 cover paper). Key claims: 80% of aging is lifestyle, not genetics; 70% of heart attacks have no antecedents; Fountain Life finds 2% of healthy adults have undetected cancers and 2.5% have aneurysms. Sinclair reports reversing mouse blindness through epigenetic reprogramming, and — in an unpublished scoop — doing it multiple times (reverse, age out, reverse again). He estimates longevity escape velocity at ~10 years out (matching Kurzweil; George Church says 15). His father, at 83, is biologically younger than his chronological age through lifestyle + supplements. Sinclair’s student developed biological age testing (Tally Health) bringing cost from $100 to under $1. Economic argument: one additional healthy year = $86 trillion for the US alone (Andrew Scott calculation). Sinclair frames the 120-year “limit” as nonsensical — “it’s a software problem, I’m putting my career on the line.”

Key arguments / segments

• [00:01:00] Introduction: aging as a disease, heart attack statistics, Fountain Life cancer/aneurysm detection rates
• [00:06:00] Gene therapy for age reversal vs. cheap chemical alternatives; democratization of longevity tech
• [00:08:00] $86 trillion economic value of one healthy year (US alone); technology cost curves
• [00:10:00] Framing the longevity question: not “how long” but “how healthy” — Health span vs. lifespan
• [00:13:00] Longevity mindset: Sinclair’s father at 83, biologically younger, got a puppy
• [00:20:00] AI feeding research papers; exponential acceleration of aging breakthroughs
• [00:24:00] Epigenetic age reversal is repeatable in mice (unpublished at time of recording)
• [00:26:00] Longevity escape velocity: Sinclair says ~10 years, Kurzweil agrees, Church says 15
• [00:31:00] “No biological limit” — aging is a software problem with a backup copy
• [00:33:00] Morality of living longer: overpopulation and resource concerns are demonstrably false

Bias / commercial flags

• Extended Levels ad read mid-episode (~2 min)
• Sinclair has commercial interests: Metro Biotech (NAD), Tally Health (biological age testing)
• Diamandis has commercial interests: Fountain Life, Vaxxinity (pcsk9 vaccine mentioned)

RDCO relevance

Low direct relevance. The “software problem” framing and backup-copy metaphor are interesting analogies for information systems but no actionable AI/data signal. Sinclair’s mention of using AI to triage research papers is a minor data point on AI-augmented research workflows.